Stock 4369 TRI CHEMICAL LABORATORIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Tri Chemical Laboratories Inc.

Equities

4369

JP3636000006

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-02 am EDT 		5-day change 1st Jan Change
4,310 JPY +0.23% Intraday chart for Tri Chemical Laboratories Inc. -0.12% +19.39%
Mar. 20 Tri Chemical's Attributable Profit Nearly Halves in Fiscal Year Ended January MT
Mar. 15 Tri Chemical Laboratories Inc. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending January 31, 2025 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's profit outlook over the next few years is a strong asset.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 33.35 times its estimated earnings per share for the ongoing year.
  • Based on current prices, the company has particularly high valuation levels.
  • The company appears highly valued given the size of its balance sheet.
  • The company is not the most generous with respect to shareholders' compensation.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
TRI CHEMICAL LABORATORIES INC. Stock Tri Chemical Laboratories Inc.
+19.39% 916M -
ECOLAB INC. Stock Ecolab Inc.
+14.70% 65.04B
A-
SIKA AG Stock Sika AG
-1.61% 47.76B
A-
GIVAUDAN SA Stock Givaudan SA
+14.58% 40.72B
B+
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+20.84% 26.88B
A-
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+9.54% 19.29B
C+
CELANESE CORPORATION Stock Celanese Corporation
+1.16% 17.53B
B+
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.87% 16.03B
A-
SYMRISE AG Stock Symrise AG
+1.11% 15.17B
B+
ALBEMARLE CORPORATION Stock Albemarle Corporation
-11.34% 15.06B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 4369 Stock
  4. Ratings Tri Chemical Laboratories Inc.